Primitive neuroectodermal tumor is a small round cell malignancy which rarely involves the orbit. We report a case of a two-year old male child presenting as unilateral eccentric
of paraproteins and/ or light chain moiety. The criteria for diagnosis of SEMP include negative lymph node assessment, skeletal survey, bone marrow biopsy and CT. In the present case the patient though presented with proptosis and no skeletal involvement, had positive bone marrow biopsy, renal insufficiency, anemia and multiple plasmacytomas. Orbital involvement is a rare presentation of the disease. [1, 2, 4] Unilateral proptosis is the most common form of orbital involvement. On computerized Medline search we found only five case reports of bilateral proptosis in multiple myeloma [3, [5] [6] [7] [8] and only seven previous cases of cytological diagnosis. [4] Orbital myeloma most commonly presents as a unilateral solitary soft tissue intraorbital tumor which is an extension of bony deposit and is associated with bone destruction. [9] In the present case multiple well-defined soft tissue tumors were not associated with bony lesions. In all previously described orbital multiple myeloma cases, soft tissue masses were seen to infiltrate the globe or muscles and skeletal survey showed radiolucent areas on skull. [3, [5] [6] [7] [8] In our case there was also presence of small paraspinal soft tissue masses without bony involvement, and radiological features simulated secondaries and lymphomas. The diagnosis could only be established after bone marrow and biochemical investigations in the present case. Histopathological picture was suggestive of multiple myeloma and immunofixation confirmed the diagnosis of IgG multiple myeloma. It is essential to rule out systemic involvement by intensive workup in cases presenting as a solitary orbital plasmacytoma as the treatment and prognosis differs with systemic involvement. [10, 11] The diagnosis of multiple myeloma should be kept in mind in cases of bilateral proptosis. Bony involvement is not universal in cases of orbital myeloma. Early diagnosis can be established with extensive biochemical and histopathological investigations and timely treatment is lifesaving for these patients.
Multimodality treatment approach in management of primary peripheral primitive neuroectodermal tumor of the orbit proptosis with extraconal and intraconal mass, diagnosed as primary peripheral primitive neuroectodermal tumor (pPPNET) on histopathology and immunohistochemistry. There is no defined consensus in the management of these tumors due to its rare presentation. We describe its distinguishing features with emphasis on multimodal and aggressive treatment approach which ensures appropriate management of these cases. Primitive neuroectodermal tumor (PNET) is a broad term that includes a wide array of lesions with varying differentiating potential affecting both the central and peripheral nervous system. [1] These are small round cell tumors of neuroectodermal origin with high malignant potential. Peripheral PNET has been grouped into "Askin" tumor (most common; thoracopulmonary region), pigmented neuroectodermal tumor and Ewing's Vol. 57 No. 5 sarcoma/PNET group (extraosseous Ewing's group). [2] To the best of our knowledge till now only nine cases of orbital involvement have been reported in literature. [3] Herein we report an additional case of this rare entity.
Case Report
A two-year-old male child presented with history of progressive prominence of the right eye for the past three months. On external ocular examination there was an upward and lateral deviation of the right eye with eccentric proptosis. The child was not cooperative for visual assessment. Anterior segment examination of the right eye was unremarkable except for a sluggish pupillary response; however, there was no relative apparent pupillary defect. Fundus evaluation of the right eye showed choroidal folds with normal optic disc. The patient had undergone magnetic resonance imaging (MRI) three months earlier, suggestive of an ovoid-shaped, contrast enhancing lesion measuring 2.59 x 2.06 x 1.86 mm, involving the inferomedial quadrant of the right orbit pushing the globe upward and laterally. The lesion was indistinguishable from the inferior rectus, inferior oblique and medial rectus muscles, however, the optic nerve was normal. Left orbit and brain scans were normal [ Fig. 1 ].
Subsequent imaging by computed tomography (CT) scan showed increase in the size of the lesion that involved both extraconal and intraconal compartments of the right orbit. The lesion was now engulfing the optic nerve sheath complex [ Fig. 1 ].
An incision biopsy of the mass was done via inferior transconjunctival approach. Paraffin sections were stained with Hematoxylin-Eosin and Periodic Acid-Schiff stains. Histopathologic examination of the tumor revealed diffuse collection of small malignant round to oval cells [ Fig. 2 ]. Cells had vesicular nuclei, inconspicuous nucleoli, scanty cytoplasm and exhibited high mitotic activity (6 MF/HPF) with rosette formation in some areas. The PAS reaction was negative. Sections were studied immunohistochemically for HIC-2 gene (CD99), neuron-specific enolase (NSE), myoglobin, desmin, CD45 and Factor VIII. The majority of cells were positive for HIC-2 gene and NSE. Based on the above findings the patient was diagnosed to have PNET of the right orbit. Extensive systemic investigations were done subsequently to rule out any other foci of tumor, these included complete hemogram, CT thorax, ultrasonography of abdomen and pelvis, bone scan and bone marrow biopsy. These were all normal and therefore diagnosis of primary orbital malignancy was made.
The child was subsequently treated with 12 cycles of chemotherapy which included six cycles of vincristine, adriamycin and cyclophosamide alternating with six cycles of ifosfamide and etoposide. This was followed with external beam radiotherapy of 44 Gy dose over 22 fractions. Serial orbital imaging was done every four months, showing a gradual reduction in the mass. Last CT scan done at the end of 30 months of follow-up showed no evidence of local recurrence or residual disease [ Fig. 3] . As a known side-effect of radiotherapy, the child developed a posterior subcapsular cataract in the right eye. Parents were explained the need for regular follow-up, six-monthly for first two years and then yearly.
Discussion
PNET is a malignancy which usually peaks in adolescents and young adults with no gender bias. [3] They are classified under Ewing's family of tumors (extraosseous type), with which it shares histopathological and cytogenetic similarity, that is, translocation t(11;22)(q24;q12). [4, 5] Microscopically, primary peripheral PNET is cellular tumor with characteristic small round cells with hyperchromatic nuclei, and a high nuclear-cytoplasmic ratio. Ultrastructural studies by electron microscopy show cytoplasmic filaments and neurosecretory granules. [5] This may aid in the diagnosis of neuroectodermal tumor and to differentiate it from extraosseous Ewing's sarcoma. [2, 5] There are varying degrees of neuronal differentiation, beginning with NSE expressivity, followed by Homer-Wright rosette formation, phenotypic ganglion cell differentiation, and finally by neurofilament protein expression. [6] Presence of Homer-Wright rosettes is associated with these tumors but it is not diagnostic of these tumors. [7] Our case was NSE-positive with presence of rosettes. The differential diagnosis of primary peripheral PNET of orbit includes Ewing's sarcoma, lymphoma, neuroblastoma, hemangioblastoma and small cell osteogenic sarcoma. [6] Immunohistochemistry helps in differentiating this entity from other tumors. Negative PAS reaction rules out Ewing's sarcoma. Lack of staining with desmin and myoglobin excludes the possibility of rhabdomyosarcoma. CD45 helps to differentiate it from lymphoma and Factor VIII to rule out vascular tumors. However, specific immunocytological markers for primary peripheral PNET are HIC-2 gene (CD 99), [8] NSE and synaptophysin and glial fibrillary acidic protein (GFAP). [9] The first two cytological markers were positive in our case, thus confirming the diagnosis of primitive neuroectodermal tumor.
Out of nine previous reported cases of isolated orbital PNET, [2, 3, 10] age group varied from less than one year to 13 years with two cases reported in adults (52 years and 28 years). There was a predilection for lateral orbit in five cases, inferior orbit in three cases and superior orbit in one case. Bony involvement was present in three cases. In our case, tumor was present initially in the inferior orbit but rapidly involved both intraconal and extraconal compartments, although there was no bony involvement. Management varied as three cases were treated with external beam radiotherapy and two cases with bone involvement were managed by both external beam radiotherapy and chemotherapy. The remaining four patients were not given additional chemotherapy or radiotherapy. We managed our case with 12 cycles of chemotherapy followed by external beam radiotherapy with successful reduction in the mass with no recurrence. Long-term follow-up is mandatory in the management of neuroectodermal tumors as metastasis and recurrence are known in this group. Moreover, as these children are on long-term chemotherapeutic drugs, they should be observed for treatment-related secondary malignancies. Our case has been followed up for 30 months and has no recurrence of the disease.
Primary peripheral PNET of the orbit is a rare entity that poses a diagnostic challenge. Imaging and histopathology though supportive do not confirm the diagnosis. Immunocytology helps in the confirmation of diagnosis. Management should be aggressive using multimodality treatment approach given at the appropriate time. These patients should be followed up for life to rule out recurrence, metastasis and treatment-related malignancies.
Mefenamic acid-induced bilateral transient myopia, secondary angle closure glaucoma and choroidal detachment
Parag Vishwakarma, Ganesh V Raman, P Sathyan Drug-induced secondary angle closure is quite common and in the majority of cases simply stopping the medication leads to rapid reversal of the condition and resolution of glaucoma. We describe here a patient who presented with secondary angle closure glaucoma and myopia following mefenamic acid ingestion which was managed successfully by stopping the medication, symptomatic treatment and reassurance. Transient myopia with bilateral secondary angle closure glaucoma is a well-documented complication of several drugs such as topiramate, [1] sulfanilamides, [2, 3] hydrochlorthiazide, [4] and acetazolamide. [5] Although nonsteroidal anti-inflammatory drugs (NSAIDs) [6] have been known to cause transient myopia they have so far not been reported with secondary angle closure glaucoma. When such an episode occurs, rapid resolution is effected by stopping the medication and observation as in the majority of patients the symptoms are transient. We report a case of secondary angle closure glaucoma following ingestion of mefenamic acid.
Case Report
A 30-year-old male patient presented to us with diminution of vision, associated with pain, and colored haloes in both eyes for two days. He had been suffering from headache for one week before presentation for which he was prescribed meftal tablet 500 mg (mefenamic acid, Blue Cross Laboratories Ltd, India) by a local general practioner. He gave a history of having taken one tablet each four days apart following which his present symptoms commenced. He consulted a local ophthalmologist in his hometown who measured the intraocular pressure (IOP) (by Schiotz tonometer -unrecordably high) and prescribed eye drops timolol maleate 0.5% twice daily, pilocarpine 2% thrice daily, chloramphenicol-dexamethasone combination four times daily and tablet acetazolamide 250 mg thrice daily. The patient used the prescribed medication for one day before he presented to us. With the evidence before us we came to the provisional diagnosis of bilateral secondary drug-induced angle closure glaucoma. The patient was advised eye drops timolol maleate 0.5% twice daily, dexamethosone 1% four times daily for both eyes and advised to review after seven days. On follow-up after seven days the patient was symptomatically better. His BCVA was 20/20 (N6) both eyes without correction. Anterior segment revealed no circumcornal congestion, clear cornea, deep anterior chamber (van Herricks Grade 4), normal reacting pupil and a clear lens. IOP by applanation tonometry was 10 mmHg both eyes and gonioscopy revealed 360° Grade 3 open angles in both eyes. Dilated fundus examination revealed normal optic discs with healthy neuroretinal rims in both eyes USG B-scan showed resolution of choroidal detachment [ Figs 3 and 4) . The patient was advised to avoid tablet mefenamic acid and review periodically.
Discussion
Drug-induced angle closure glaucoma with induced myopia with choroidal detachment is a well-known entity of many sulphinamide [2] -derived medications such as acetazolamide, hydrochlorthiazide and sulphonamides, promethazine, spironolactone, isosorbide dinitrate, bromocriptine, corticosteroids, penicillamine, quinine, metronidazole, and isotretinoin. Recently, bilateral angle closure glaucoma with uveal
